# HCV Post-Exposure Prophylaxis for Health Care Workers

> **NCT03313414** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Sofosbuvir/Velpatasvir Treatment for 14 days

## Key facts

- **NCT ID:** NCT03313414
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08-13
- **Primary completion:** 2020-01
- **Final completion:** 2020-01-16
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participant enrollment, funding withdrawn.
- **Last updated:** 2020-01-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03313414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03313414, "HCV Post-Exposure Prophylaxis for Health Care Workers". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03313414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*